Lemierre's Syndrome in an Aseptic Patient with Systemic Lupus Erythematosus

Isr Med Assoc J. 2018 Jul;20(7):448-450.

Authors

Hymie H Chera¹, Max Cohen², Robert Ishakis³, Yitzhak Rosen¹, David J Ozeri⁴

Affiliations

¹ Department of Medicine and Rheumatology, State University of New York, Downstate Medical Center, Brooklyn, NY, USA.
² College of Osteopathic Medicine, New York Institute of Technology, Glen Head, NY, USA.
³ Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
⁴ Department of Medicine, Division of Rheumatology, New York Presbyterian Brooklyn Methodist Hospital, Brooklyn NY, USA.

PMID: 30109797

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Anticoagulants / therapeutic use
Enzyme Inhibitors / therapeutic use
Female
Heparin, Low-Molecular-Weight / therapeutic use
Humans
Hydroxychloroquine / therapeutic use
Lemierre Syndrome / diagnosis
Lemierre Syndrome / drug therapy
Lemierre Syndrome / etiology*
Lupus Erythematosus, Systemic / complications*
Lupus Erythematosus, Systemic / drug therapy
Mycophenolic Acid / therapeutic use
Tomography, X-Ray Computed

Substances

Anticoagulants
Enzyme Inhibitors
Heparin, Low-Molecular-Weight
Hydroxychloroquine
Mycophenolic Acid